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ABSTRACT 
The behavior of  2-ethoxycarbonyl-4H-3,1-benzoxazin-4-one and its behavior towards nitrogen nucleophiles namely, 
hydrazine hydrate, formamide, benzylamine, ethylamine, piperidine, ethanol amine, o-phenylenediamine, and 
glucosamine hydrochloride has been investigated. Also the reaction of 3-[aminoquinazolin-4(3H)-one-2-yl]formic acid 
hydrazide with aromatic aldehydes and phenylisothiocyanate has been discussed. The structure of the prepared 
compounds are elucidated using physical and spectral data like, FT-IR, 
1
HNMR, and mass spectroscopy. 
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INTRODUCTION 
Potent benzoxazinones are inhibitors for human leukocyte elastase (HLE) [1], human Cathepsin G, and bovine 
chymotrypsin [2]. Also, the inhibition of Chymotrypsin-like and Elastase-like serine proteases by 4H-3,1-benzoxazin-4-
ones has been investigated [3]. In addition many fused pyrimidines such as quinazolinones have been reported to exhibit 
anti-inflammatory [4], antimicrobial [5], anticancer [6], and antimalarial [7] activities. Quinazolin-4(3H)-ones are frequently 
encountered unit in natural products such as L-Vasicinone[8] and Chrysogine [9]. For the above findings and in 
continuation of our program [10-15] on the synthesis of novel heterocyclic systems exhibiting biological activity, we 
synthesis a varieties of quinazolinone derivatives via the interaction of the benzoxazinone derivative 2 with different 
nitrogen nucleophiles. Firstly, with the aim of obtaining more precise information about the course of the reaction and 
some interesting pharmaceutical compounds. Also compound 2 so called dynamic benzoxazinone derivative due to the 
electron attracting power of the ethoxycarbonyl group at the 2-position increases the electronically unsaturated character 
of the oxazinone ring and increases its affinity towards nucleophiles. This is the second target which we want to prove it in 
this study. 
EXPERIMENTAL 
General procedure 
Reagents and solvents were used as obtained from the supplier without further purification. All melting points reported are 
uncorrected and were determined on a Stuart electric melting point apparatus. Elemental analysis were carried out in the 
Micro Analytical Center, Cairo University, Giza, Egypt. Thin-layer chromatography (TLC) was performed on Merk TLC 
aluminium sheets silica gel 60 F254 with detection by UV quenching at 254nm. 
1
H NMR spectra were recorded on a Bruker 
400 MHz spectrometer, with residual proton signal of the deuterated solvent as the internal reference (H=7.26 ppm for 
CDCl3 and H=2.51 ppm for DMSO-d6). Chemical shifts () are given in parts per million (ppm). IR spectra were recorded 
on Nicolet Impact 400D FT-IR apparatus using OMNIC program and are reported in terms of frequency of absorption (cm
-
1
). EIMS were recorded on a gas chromatographic GCMS – Qploopx Shimadzu (Japan, 1990). 
Formation 1 and 2 
A solution of anthranilic acid (1.37g, 0.1 mol) and diethyloxalate (1.46g, 0.1 mol) in n-butanol (30 mL) was refluxed for 6h. 
The solid that separated after concentration was filtered off and crystallized from DMF to give 1 as colorless crystals.  The 
solid that separated after concentration the mother liquor was filtered off and crystallized from n-BuOH to give the 
benzoxazinone 2 as pale yellow crystals. 
2-(Ethoxycarbonylformylamino)benzoic acid (1): Yield 65%. M.p. >300 C. IR (KBr): 1675, 1701, 1744 
(CO), 3266 cm
-1
 (CH-arom.). 
1
H NMR (DMSO-d6):  1.00 (t, J=7Hz, 3H, CH3), 4.13 (q, J=7Hz, 2H, CH2), 6.24 (brs, 1H, 
NH, D2O exchangable), 7.32-8.14 (m, 4H, Ar-H), 12.1 (s, 1H, OH). Anal. Calc. for C11H11NO5 (237): C 55.69, H 4.64, N 
5.90; found: C 55.72, H 4.70, N 6.00. 
2-Ethoxycarbonyl-4H-3,1-benzoxazin-4-one (2): Yield 74%. M.p. 130 C. IR (KBr): 1721, 1744 cm-1 (CO). 1H 
NMR (DMSO-d6):  1.15 (t, J=7Hz, 3H, CH3), 4.16 (q, J=7Hz, 2H, CH2), 7.29-7.94 (m, 4H, Ar-H). Anal. Calc. for C11H9NO4 
(219): C 60.27, H 4.10, N 6.39; found: C 60.34, H 4.18, N 6.44. 
(Quinazolin-4(3H)-one-2-yl)formamide (3) 
A solution of 2 (2.19g, 0.1 mol) and formamide (10 mL) was heated under reflux for 3h. The reaction mixture was diluted 
with H2O and the solid that separated filtered off and crystallized from DMF to give 3 as colorless crystal. Yield 69%. M.p. 
>300 C. IR (KBr): 1661, 1680 (CO), 3137, 3200 cm
-1
 (NH). 
1
H NMR (DMSO-d6):  7.36-8.03 (m, 4H, Ar-H), 9.39 (brs, 2H, 
NH2, D2O exchangable), 13.9 (brs, 1H, NH, D2O exchangable). Anal. Calc. for C9H7N3O2 (189): C 57.14, H 3.70, N 22.22; 
found: C 57.50, H 4.00, N 22.25. 
(3-Benzyl-quinazolin-4(3H)-one)-N-benzylformamide (4) 
A mixture of 2 (2.19g, 0.01 mol) and benzylamine (1.06g, 0.01 mol) in ethanol (30 mL) was heated under reflux for 3h. The 
solid that separated after cooling was filtered off and crystallized from ethanol to give 4 as colorless crystals. Yield 62%. 
M.p. 198 C. IR (KBr): 1661, 1672 (CO), 3210 cm
-1
 (NH). Anal. Calc. for C23H19N3O2 (369): C 74.79, H 5.14, N 11.38; 
found: C 74.79, H 5.35, N 11.46. MS: m/z  370[M
+
] (19.2%), 278(26.8%), 264(100%), 235(13.4%), 134 (39.8%). 
2-[(2-Alkylamino-2-alkylcarbamoyl)azavinyl]benzoic acid (5a-c) 
An equimolar ratio of 2 (0.01 mol), appropriate amine namely, ethylamine, ethanolamine, and piperidine (0.01 mol) in 1,4-
dioxane (30 mL) was heated under reflux for 3h. The solid that separated after cooling was filtered off and crystallized 
from the proper solvent to give 5a-c. 
2-[(2-Ethylamino-2-ethylcarbamoyl)azavinyl]benzoic acid (5a): Yield 72% (colorless). M.p. >300 C 
(acetic acid). IR (KBr): 1605 (C=N), 1677, 1700 (CO), 3270 (NH), 3400 cm
-1
 (OH). Anal. Calc. for C13H17N3O3 (263): C 
59.31, H 6.46, N 15.96; found: C 59.71, H 6.86, N 16.28. 
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2-[(2-Hydroxyethylamino-2-hydroxyethylcarbamoyl)azavinyl]benzoic acid (5b): Yield 66% (pale 
yellow). M.p. 290-292 C (methanol). IR (KBr): 1603 (C=N), 1678, 1700 (CO), 3266 (NH), 3450 cm
-1
 (chelated OH). Anal. 
Calc. for C13H17N3O5 (295): C 52.88, H 5.76, N 14.23; found: C 52.48, H 5.56, N 14.63. 
2-[(2-Piperidino-2-piperidinocarbamoyl)azavinyl]benzoic acid (5c): Yield 63% (pale yellow). M.p. 180-
182 C (methanol). IR (KBr): 1600 (C=N), 1667, 1690 (CO), 3425 cm
-1
 (chelated OH). Anal. Calc. for C19H25N3O3 (343): C 
66.47, H 7.28, N 12.24; found: C 66.21, H 7.58, N 12.56. 
5,6-Benzo-2-oxo-1,2-dihydropyrazino[4,3-b]quinazolin-4(3H)-one (6) 
A mixture of 2 (2.19g, 0.01 mol) and o-phenylene diamine (1.07g, 0.01 mol) in toleuene (30 mL) was heated under reflux 
for 5h. The solid that separated after cooling was filtered off and crystallized from glacial acetic acid to give 6 as brown 
crystals. Yield 74%. M.p. 297-298 C. IR (KBr): 1457, 1579, 1628 (ring vibration of quinazolone ring), 1672 (CO), 3280 cm
-
1
 (NH). 
1
H NMR (CDCl3):  7.31-8.36 (m, 8H, Ar-H), 10.56 (brs, 1H, NH, D2O exchangable). Anal. Calc. for C15H9N3O 
(263): C 68.44, H 3.42, N 15.96; found: C 68.40, H 3.15, N 15.90. 
3-Glucosyl-2-N-glucosylcarbamoylquinazolin-4(3H)-one (7) 
A solution of 2 (2.19g, 0.01 mol) and glucosamine hydrochloride (2.16g, 0.01 mol) in pyridine (15 mL) was refluxed for 3h. 
The reaction mixture was poured onto ice cold dil. HCl. The solid that separated was filtered off and crystallized from 
ethanol to give 7 as beige crystals. Yield 67%. M.p. 290-292 C. IR (KBr): 1452, 1531, 1633 (ring vibration of quinazolone 
ring), 1692, 1695 (CO), 3231 (NH), 3383 cm
-1
 (chelated OH). Anal. Calc. for C21H27N3O12 (513): C 49.12, H 5.26, N 8.18; 
found: C 49.00, H 5.20, N 8.07. MS: m/z  351[M
+
- C6H11O5] (12.7%), 264(43.0%), 235(17.6%), 206(100%), 163(31.2%), 
134 (8.9%). 
3-Amino-2-hydrazinocarbonylquinazlin-4(3H)-one (8) 
A solution of compound 2 (2.19g, 0.01 mol) and hydrazine hydrate (1.5g, 0.03 mol) in ethanol (30 mL) was heated under 
reflux for 6h. The solid that separated on cooling was filtered off and crystallized from n-BuOH to give 8 as beige crystals. 
Yield 71%. M.p. 260-262 C. IR (KBr): 1453, 1517, 1630 (ring vibration of quinazolone ring), 1680, 1697 (CO), 3212, 3318 
cm
-1
 (NH). Anal. Calc. for C9H9N5O2 (219): C 49.31, H 4.10, N 31.96; found: C 49.26, H 3.92, N 31.56. 
(3-Arylideneaminoquinazolin-4(3H)-one-2yl)-N-aminoformamide (9a,b) 
A solution of compound 8 (2.19g, 0.01 mol) and aromatic aldehyde namely, benzaldehyde and/or 4-methoxybenzaldehyde 
(0.015 mol) in ethanol (30 mL) and few drops of piperidine was added and the reaction mixture was refluxed for 6h. The 
solid that separated after cooling was crystallized from n-BuOH to give 9a,b respectively. 
(3-Benzylideneaminoquinazolin-4(3H)-on-2-yl)-N-aminoformamide (9a): Yield 67% (brown). M.p. 
>300 C. IR (KBr): 1509, 1585, 1634 (ring vibration of quinazolone ring), 1664, 1700 (CO), 3254, 3260 cm
-1
 (NH).
 1
H NMR 
(CDCl3):   7.36-7.95 (m, 6H, Ar-H & olefinic-H), 8.11-8.72 (m, 3H, Ar-H), 9.12 (s, 1H, NH), 12.79 (s, 1H, NH), 12.83 (s, 
1H, NH). Anal. Calc. for C16H13N5O2 (307): C 62.54, H 4.23, N 22.80; found: C 62.12, H 4.46, N 22.48.  
[3-(4-Methoxybenzylideneaminoquinazolin-4(3H)-on-2-yl)-N-aminoformamide (9b):Yield 69% 
(beige). M.p. >300 C. IR (KBr): 1419, 1507, 1601 (ring vibration of quinazolone ring), 1663 (CO), 3210, 3249 cm
-1
 (NH). 
Anal. Calc. for C17H15N5O3 (337): C 60.53, H 4.45, N 20.77; found: C 60.72, H 4.32, N 20.35. 
 
Formation of 10a,b 
A solution of compound 8 (2.19g, 0.01 mol) and aromatic aldehydes namely 4-chlorobenzaldegyde and/or 4-
nitrobenzaldegyde (0.02 mol) in dimethyl formamide (30 mL) was heated under reflux for 3h. The reaction mixture was 
diluted with water and the solid that separated was filtered off and crystallized from acetic acid to give 10a,b as pale yellow 
crystals respectively. 
[3-(4-Chlorobenzylideneaminoquinazolinon-2-yl]-4-chlorobenzylideneamino formamide (10a): 
Yield 67%. M.p. 237-238 C. IR (KBr): 1401, 1516, 1558 (ring vibration of quinazolone ring), 1665 (CO), 3281 cm
-1
 (NH). 
1
H NMR (CDCl3):   7.26-8.34 (m, 13H, Ar-H & olefinic-H), 8.79 (s, 1H, olefinic-H), 12.94 (s, 1H, NH). Anal. Calc. for 
C23H15N5O2Cl (246.4): C 59.48, H 3.23, N 15.08; found: C 59.48, H 3.18, N 15.51. 
[3-(4-Nitrobenzylideneaminoquinazolinon-2-yl]-4-nitrobenzylideneamino formamide (10b): 
Yield 59%. M.p. 263-265 C. IR (KBr): 1409, 1522, 1587 (ring vibration of quinazolone ring), 1681 (CO), 3254 cm
-1
 (NH). 
Anal. Calc. for C23H15N7O6 (485): C 56.90, H 3.09, N 20.20; found: C 56.38, H 3.12, N 20.46. 
Triazinoquinazolinone 11 
A mixture of compound 8 (2.19g, 0.01 mol) and phenylisocyanate (2.68g, 0.02 mol) in dimethyl formamide (30 mL) was 
heated under reflux for 3h. The reaction mixture was diluted with water and the solid that separated was filtered off and 
crystallized from toluene to give 11 as pale yellow crystals. 
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Yield 66%. M.p. 273 C. IR (KBr): 1388 (C=S), 1691 (CO), 3151, 3222 cm
-1
 (NH). Anal. Calc. for C23H17N7O2S (455): C 
60.65, H 3.73, N 21.53; found: C 60.54, H 3.60, N 21.43. 
 
RESULTS AND DISCUSSION 
2-Ethoxycarbonyl-4H-3,1-benzoxazin-4-one (2) was obtained via the interaction of diethyloxalate with anthranilic acid in 
boiling n-butanol via ring closure of isolated anthranil intermediate 1. Also the benzoxazinone derivative 2 was obtained 
from dehydration of compound 1 with Ac2O (Scheme 1). 
Considering the structure of 4H-3,1-benzoxazin-4-one derivatives; there are two sites available for nucleophilic attack C(2) 
and C(4), i.e, two different sites with partial positive charge that can lead to the opening of the oxazinone nucleus by 
different nucleophiles. In most cases, reclosure of the heterocyclic part of the molecule is favored and provides a new 
compound with interesting chemical and biological properties [16]. 
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Scheme 1 
In this respects, the reaction of benzoxazinone 2 with formamide or benzylamine yielded quinazolin-4(3H)-one-2-
ylformamide and 3-benzylquinazolin-4(3H)-one-2-yl-N-benzylformamide 3 and 4 respectively (Scheme 3). One can 
interpret these results as follows: the N-nucleophiles are attacking the benzoxazinone 2 in a fashion in which the amino 
group first undergoes H-bonding to the N-atom of the heterocycle. Then, the amino group reacts by nucleophilic addition 
at the activated azavinylic C(2) (activated by the ethoxycarbonyl group) to form an inner amidinium salt [12], which 
subsequently is dehydrated to give the quinazolinone derivative (Scheme 2). 
On the other hand, 4H-3,1-benzoxazin-4-one 2 reacted with ethylamine, ethanolamine, and piperidine in 1,4-dioxane and 
yielded the corresponding 2-(disubstituted azamethylene)benzoic acid 5a-c (Scheme 3). IR spectra of compound 5 
revealed strong absorption bands at 1685-1700 cm
-1 
attributable to νC=O
 
of carboxyl and devoid any band for 
ethoxycarbonyl group. When the benzoxazinone 2 was submitted to react with o-phenylene diamine in toleuene yielded 
the bridge head nitrogen compound 6 (Scheme 3). IR spectrum of compound 6 devoid any band for ethoxycarbonyl group. 
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Scheme 2 
Glycosyl heterocycles and their nucleoside analogues have multiple potential applications. Significant progress with such 
analogues has led to advances in Cancer chemotherapy and anti-HBV and HIV applications. The lack of an effective 
therapy to treat hepatitis B virus and HIV infections, particularly in chronic cases, has focused considerable effort into the 
synthesis of nucleoside analogues possessing antiviral activity [17-19]. Some analogues having either modified bases 
and/or glycosyl residues have shown promising antiparasitic chemotherapy [20]. An area of intensive research is in the 
design of nucleoside analogues where in the aglycone moieties are altered while biological activity is retained. This type of 
novel design of nucleoside analogue pertains to modified nucleobases which are of neither the purine nor pyrimidine 
types. In this regards, quinazolin-4(3H)-one (benzopyrimidine derivative) ring has attracted our attention. Thus, when 
compound 2 was allowed  to react with glucoseamine hydrochloride in dry pyridine yielded 3-glycosyl-2-N-
glucosylcarbamoyl quinazoline 7 (Scheme 3). 
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Scheme 3 
Heating 4H-3,1-benzoxazin-4-one 2 in hydrazine hydrate in boiling ethanol produced the 3-amino-2-hydrazinocarbonyl 
quinazolinone 8 (Scheme 3). The reaction takes place via heteroring opening followed by cyclisation and nucleophilic 
attacks by hydrazine on carbonyl group of ethoxycarbonyl function. The above results are in agreement with our 
assumption of a nucleophilic attack at C(2). On the other hand, they are in disagreement with previous results which 
account for the formation of 3-aminoquinazoline to rationalize the hydrazinolysis reaction in the presence of anhydrous 
ZnCl2 [21] or when the substituent at C(2) is sterically bulky [22]. 
Moreover, quinazolinone derivative 8 was used as key starting material for synthesizing Schiff`s bases derivatives 9 and 
10 via interaction of quinazolinone 8 with aromatic aldehydes like benzaldehyde, 4-methoxybenzaldehyde, 4-
chlorobenzaldehyde, and 4-nitrobenzaldehyde. Thus, when the quinazolinone derivative 8 was allowed to react with 
benzaldehyde and/or 4-methoxybenzaldehyde yielded the Schiff`s bases 9a,b. On the other hand, 4-chlorobenzaldehyde 
and 4-nitrobenzaldehyde when submitted to react with quinazolinone 8 afforded the bis compound 10a,b (Scheme 4). 
Finally, the quinazolinone derivative 8 was used in synthesis of triazinoquinazolinone. Thus, when compound 8 was 
submitted to react with phenyl isothiocyanate in boiling dimethyl formamide afforded the triazino-quinazolinone derivative 
11 (Scheme 4). 
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